Poty et al.
2018
α-emitters for radiotherapy: from basic radiochemistry to clinical studies—part 1
Pallares et al.
2022
Development of radiopharmaceuticals for targeted alpha therapy: Where do we stand?
Kratochwil et al.
2016
225Ac-PSMA-617 for PSMA-targeted α-radiation therapy of metastatic castration-resistant prostate cancer
Wild et al.
2011
Alpha-versus beta-particle radiopeptide therapy in a human prostate cancer model (213Bi-DOTA-PESIN and 213Bi-AMBA versus177Lu-DOTA-PESIN)
Poty et al.
2018
α-emitters for radiotherapy: from basic radiochemistry to clinical studies—part 2
Kelly et al.
2019
Albumin-binding PSMA ligands: implications for expanding the therapeutic window
Lin et al.
2024
Peptide binder to glypican-3 as a theranostic agent for hepatocellular carcinoma
Benešová et al.
2015
Preclinical evaluation of a tailor-made DOTA-conjugated PSMA inhibitor with optimized linker moiety for imaging and endoradiotherapy of prostate cancer
Miao et al.
2005
Therapeutic efficacy of a 188Re-labeled α-melanocyte–stimulating hormone peptide analog in murine and human melanoma-bearing mouse models
CN110612126B
(zh )
2023-11-03
可用于成像和抗肿瘤治疗的具有可调的药代动力学的三功能构建体
Kasbollah et al.
2013
Review on production of 89Zr in a medical cyclotron for PET radiopharmaceuticals
Béhé et al.
2005
Use of polyglutamic acids to reduce uptake of radiometal-labeled minigastrin in the kidneys
Maguire et al.
2014
Efficient 1-step radiolabeling of monoclonal antibodies to high specific activity with 225Ac for α-particle radioimmunotherapy of cancer
JP2022511471A5
(cg-RX-API-DMAC10.html )
2022-12-12
JP2022516170A5
(cg-RX-API-DMAC10.html )
2023-01-19
Feng et al.
2023
Effective treatment of human breast carcinoma xenografts with single-dose 211At-labeled anti-HER2 single-domain antibody fragment
TWI878344B
(zh )
2025-04-01
放射性標記grpr拮抗劑之方法及其套組
Sanad et al.
2017
Radiodiagnosis of peptic ulcer with technetium-99 m-labeled esomeprazole
Bobba et al.
2024
Development of CD46 targeted alpha theranostics in prostate cancer using 134Ce/225Ac-Macropa-PEG4-YS5
McInnes et al.
2021
Therapeutic efficacy of a bivalent inhibitor of prostate-specific membrane antigen labeled with 67Cu
US20250340519A1
(en )
2025-11-06
Radiolabelled compound
Rogers et al.
2005
MicroPET imaging of gene transfer with a somatostatin receptor–based reporter gene and 94mTc-demotate 1
Schmitt et al.
2004
Radiation therapy of small cell lung cancer with 177Lu-DOTA-Tyr3-octreotate in an animal model
CN114404618A
(zh )
2022-04-29
放射性药物水溶液及其用途
Kersemans et al.
2008
Drug-resistant AML cells and primary AML specimens are killed by 111In-anti-CD33 monoclonal antibodies modified with nuclear localizing peptide sequences